Hinova Pharmaceuticals Inc banner
H

Hinova Pharmaceuticals Inc
SSE:688302

Watchlist Manager
Hinova Pharmaceuticals Inc
SSE:688302
Watchlist
Price: 40.5 CNY 0.87% Market Closed
Market Cap: ¥4B

Wall Street
Price Targets

Price Targets Summary
Hinova Pharmaceuticals Inc

There are no price targets for Hinova Pharmaceuticals Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hinova Pharmaceuticals Inc Competitors:
Price Targets
CPNREIT
CPN Retail Growth Leasehold REIT
7% Upside
GRP
Greencoat Renewables PLC
28% Upside

Revenue
Forecast

-39% / Year
Past Growth
733% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-39% / Year
Past Growth
733% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 5 years the compound annual growth rate for Hinova Pharmaceuticals Inc's revenue is -39%. The projected CAGR for the next 3 years is 733%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Hinova Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hinova Pharmaceuticals Inc's stock price target?
Not Available

Hinova Pharmaceuticals Inc doesn't have any price targets made by Wall Street professionals.

What is Hinova Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
733%

For the last 5 years the compound annual growth rate for Hinova Pharmaceuticals Inc's revenue is -39%. The projected CAGR for the next 3 years is 733%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett